Detalles de la búsqueda
1.
The spatial landscape of T cells in the microenvironment of stage III lung adenocarcinoma.
J Pathol
; 262(4): 517-528, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38361487
2.
Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
J Immunol
; 190(7): 3783-97, 2013 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23440412
3.
Primary hepatic angiosarcoma and potential treatment options.
J Gastroenterol Hepatol
; 29(5): 906-11, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24372769
4.
Examining the spatial distribution of tumor-infiltrating immune cells in patients with stage I-IIIA LUAD.
J Leukoc Biol
; 2024 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38236199
5.
XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial.
Signal Transduct Target Ther
; 9(1): 79, 2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38565886
6.
Vemurafenib for BRAF V600-mutant Erdheim-Chester disease presenting with bilateral orbital involvement.
Clin Case Rep
; 11(8): e7780, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37609641
7.
Pathologic complete response to immune checkpoint inhibitor in a stage IIIB ovarian clear cell carcinoma patient with POLE mutation resistant to platinum-based chemotherapy: a case report.
Gland Surg
; 11(9): 1562-1567, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-36221285
8.
A Phase IB Trial of Autologous Cytokine-Induced Killer Cells in Combination with Sintilimab, Monoclonal Antibody Against Programmed Cell Death-1, plus Chemotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 23(8): 709-719, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35995696
9.
Response to gefitinib/crizotinib combination in a pulmonary sarcomatoid carcinoma patient harboring concurrent EGFR mutation and MET amplification.
Clin Case Rep
; 9(7): e04487, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34322251
10.
Autologous cytokine-induced killer (CIK) cells enhance the clinical response to PD-1 blocking antibodies in patients with advanced non-small cell lung cancer: A preliminary study.
Thorac Cancer
; 12(2): 145-152, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33150733
11.
Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events.
Cancer Biol Med
; 2021 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34378879
12.
[Efficacy and Survival Analysis of Apatinib in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer after Failure of First-line Treatment].
Zhongguo Fei Ai Za Zhi
; 20(11): 761-768, 2017 Nov 20.
Artículo
en Zh
| MEDLINE | ID: mdl-29167006
13.
Higher preoperative platelet-to-lymphocyte ratio is a poor prognostic marker for the early stage malignant melanoma patients / 中国肿瘤生物治疗杂志
Chinese Journal of Cancer Biotherapy
; (6): 509-514, 2018.
Artículo
en Zh
| WPRIM | ID: wpr-821260
14.
Clinical significance of the monocyte-to-lymphocyte ratio in peripheral blood of patients with pulmonary sarcomatoid carcinoma / 中国肿瘤生物治疗杂志
Chinese Journal of Cancer Biotherapy
; (6): 1055-1059, 2018.
Artículo
en Zh
| WPRIM | ID: wpr-801681
Resultados
1 -
14
de 14
1
Próxima >
>>